Clinical Trial Update: A Study of LY4515100 in Participants With Pain Following Third Molar Removal [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of LY4515100 for pain after third molar extraction is listed as not yet recruiting, sponsored by Eli Lilly.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• LY4515100

Snippet

Sponsor: Eli Lilly and Company | Conditions: Acute Pain, Molar | Phase 2 | Status: NOT_YET_RECRUITING